Lele Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lele Zhang has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Ke Ding
Department of Anesthesiology Renmin Hospital of Wuhan University Wuhan China
2 shared publications - Qing-Tao Meng
Department of Anesthesiology Renmin Hospital of Wuhan University Wuhan China
2 shared publications - Rong Chen
Department of Anesthesiology Renmin Hospital of Wuhan University Wuhan China
2 shared publications - Yiguo Zhang
Department of Anesthesiology Renmin Hospital of Wuhan University Wuhan China
2 shared publications - Jie Luo
Department of Anesthesiology Renmin Hospital of Wuhan University Wuhan China
1 shared publication - Ruoshi Shi
Department of Anesthesiology Renmin Hospital of Wuhan University Wuhan China
1 shared publication
Latest Publications
- 22 January 2026
- Published by Wiley in The FASEB Journal
- Vol. 40 (2) , e71495
β ‐Hydroxybutyric Acid Inhibits Mitochondrial Biogenesis via the HDAC2 / SIRT7 Signaling Pathway After Intestinal Ischemia–Reperfusion
β ‐hydroxybutyric acid (BHB), a key ketone body with energy substrate and epigenetic regulatory roles, has contradictory effects in pathological contexts. Intestinal ischemia–reperfusion (IIR) is a life threatening perioperative complication characterized by metabolic disorders and mitochondrial dysfunction, yet BHB's role in IIR remains unclear. Using C57BL/6 mouse IIR models and Caco2 cell hypoxia‐reoxygenation (HR) models, we identified a pathogenic mechanism: IIR induced nearly 10‐fold elevation of intestinal BHB, while ketolytic enzymes 3‐hydroxybutyrate dehydrogenase 1 (BDH1) and 3‐oxoacid CoA‐transferase 1 (OXCT1) were significantly downregulated, blocking BHB's metabolic pathway. Exogenous BHB administration failed to protect the intestine; instead, it selectively inhibited expression of histone deacetylase 2 (HDAC2) (by 30%) and disrupted its nuclear binding to the Sirt7 promoter, promoting Sirt7 gene transcriptional activation (mRNA upregulated by 2‐fold). This cascade exacerbated oxidative stress (reactive oxygen species increased by 2.7‐fold), reduced adenosine triphosphate levels (by 20%), impaired mitochondrial biogenesis (decreased mitochondrial DNA copy number and mitochondrial transcription factor A (TFAM)/mitochondrial ribosomal proteins (MRPs) expression), and aggravated intestinal barrier dysfunction (Claudin‐1 reduced and D‐lactate elevated). Notably, HDAC2 overexpression or SIRT7 knockdown reversed these impairments. Our findings uncover a previously unrecognized role of BHB in exacerbating IIR injury via the HDAC2/SIRT7 pathway, providing new insights for protecting pathological intestinal tissues at ischemic risk and targeting mitochondrial biogenesis.
- 22 January 2026
- Published by Wiley in The FASEB Journal
- Vol. 40 (2) , e71495
β ‐Hydroxybutyric Acid Inhibits Mitochondrial Biogenesis via the HDAC2 / SIRT7 Signaling Pathway After Intestinal Ischemia–Reperfusion
β ‐hydroxybutyric acid (BHB), a key ketone body with energy substrate and epigenetic regulatory roles, has contradictory effects in pathological contexts. Intestinal ischemia–reperfusion (IIR) is a life threatening perioperative complication characterized by metabolic disorders and mitochondrial dysfunction, yet BHB's role in IIR remains unclear. Using C57BL/6 mouse IIR models and Caco2 cell hypoxia‐reoxygenation (HR) models, we identified a pathogenic mechanism: IIR induced nearly 10‐fold elevation of intestinal BHB, while ketolytic enzymes 3‐hydroxybutyrate dehydrogenase 1 (BDH1) and 3‐oxoacid CoA‐transferase 1 (OXCT1) were significantly downregulated, blocking BHB's metabolic pathway. Exogenous BHB administration failed to protect the intestine; instead, it selectively inhibited expression of histone deacetylase 2 (HDAC2) (by 30%) and disrupted its nuclear binding to the Sirt7 promoter, promoting Sirt7 gene transcriptional activation (mRNA upregulated by 2‐fold). This cascade exacerbated oxidative stress (reactive oxygen species increased by 2.7‐fold), reduced adenosine triphosphate levels (by 20%), impaired mitochondrial biogenesis (decreased mitochondrial DNA copy number and mitochondrial transcription factor A (TFAM)/mitochondrial ribosomal proteins (MRPs) expression), and aggravated intestinal barrier dysfunction (Claudin‐1 reduced and D‐lactate elevated). Notably, HDAC2 overexpression or SIRT7 knockdown reversed these impairments. Our findings uncover a previously unrecognized role of BHB in exacerbating IIR injury via the HDAC2/SIRT7 pathway, providing new insights for protecting pathological intestinal tissues at ischemic risk and targeting mitochondrial biogenesis.
- Open Access
- 30 May 2024
- Published by Wiley in The FASEB Journal
- Vol. 38 (11) , e23681
Ghrelin alleviates intestinal ischemia–reperfusion injury by activating the GHSR ‐1α/Sirt1/ FOXO1 pathway
Ischemia–reperfusion (IR) injury is primarily characterized by the restoration of blood flow perfusion and oxygen supply to ischemic tissue and organs, but it paradoxically leads to tissue injury aggravation. IR injury is a challenging pathophysiological process that is difficult to avoid clinically and frequently occurs during organ transplantation, surgery, shock resuscitation, and other processes. The major causes of IR injury include increased levels of free radicals, calcium overload, oxidative stress, and excessive inflammatory response. Ghrelin is a newly discovered brain‐intestinal peptide with anti‐inflammatory and antiapoptotic effects that improve blood supply. The role and mechanism of ghrelin in intestinal ischemia–reperfusion (IIR) injury remain unclear. We hypothesized that ghrelin could attenuate IIR‐induced oxidative stress and apoptosis. To investigate this, we established IIR by using a non‐invasive arterial clip to clamp the root of the superior mesenteric artery (SMA) in mice. Ghrelin was injected intraperitoneally at a dose of 50 μg/kg 20 min before IIR surgery, and [D‐Lys3]‐GHRP‐6 was injected intraperitoneally at a dose of 12 nmol/kg 20 min before ghrelin injection. We mimicked the IIR process with hypoxia‐reoxygenation (HR) in Caco‐2 cells, which are similar to intestinal epithelial cells in structure and biochemistry. Our results showed that ghrelin inhibited IIR/HR‐induced oxidative stress and apoptosis by activating GHSR‐1α. Moreover, it was found that ghrelin activated the GHSR‐1α/Sirt1/FOXO1 signaling pathway. We further inhibited Sirt1 and found that Sirt1 was critical for ghrelin‐mediated mitigation of IIR/HR injury. Overall, our data suggest that pretreatment with ghrelin reduces oxidative stress and apoptosis to attenuate IIR/HR injury by binding with GHSR‐1α to further activate Sirt1.
- 30 May 2024
- Published by Wiley in The FASEB Journal
- Vol. 38 (11) , e23681
Open AccessGhrelin alleviates intestinal ischemia–reperfusion injury by activating the GHSR ‐1α/Sirt1/ FOXO1 pathway
Ischemia–reperfusion (IR) injury is primarily characterized by the restoration of blood flow perfusion and oxygen supply to ischemic tissue and organs, but it paradoxically leads to tissue injury aggravation. IR injury is a challenging pathophysiological process that is difficult to avoid clinically and frequently occurs during organ transplantation, surgery, shock resuscitation, and other processes. The major causes of IR injury include increased levels of free radicals, calcium overload, oxidative stress, and excessive inflammatory response. Ghrelin is a newly discovered brain‐intestinal peptide with anti‐inflammatory and antiapoptotic effects that improve blood supply. The role and mechanism of ghrelin in intestinal ischemia–reperfusion (IIR) injury remain unclear. We hypothesized that ghrelin could attenuate IIR‐induced oxidative stress and apoptosis. To investigate this, we established IIR by using a non‐invasive arterial clip to clamp the root of the superior mesenteric artery (SMA) in mice. Ghrelin was injected intraperitoneally at a dose of 50 μg/kg 20 min before IIR surgery, and [D‐Lys3]‐GHRP‐6 was injected intraperitoneally at a dose of 12 nmol/kg 20 min before ghrelin injection. We mimicked the IIR process with hypoxia‐reoxygenation (HR) in Caco‐2 cells, which are similar to intestinal epithelial cells in structure and biochemistry. Our results showed that ghrelin inhibited IIR/HR‐induced oxidative stress and apoptosis by activating GHSR‐1α. Moreover, it was found that ghrelin activated the GHSR‐1α/Sirt1/FOXO1 signaling pathway. We further inhibited Sirt1 and found that Sirt1 was critical for ghrelin‐mediated mitigation of IIR/HR injury. Overall, our data suggest that pretreatment with ghrelin reduces oxidative stress and apoptosis to attenuate IIR/HR injury by binding with GHSR‐1α to further activate Sirt1.